USPTO Rules in Favor of Agilent in AP-MALDI Dispute with University of California | GenomeWeb

NEW YORK, May 18 (GenomeWeb News) - The US Patent and Trademark Office has determined that Agilent Technologies may not have been the first to the patent office, but it did beat the University of California in developing an improved method of mass spectrometry, and therefore deserves a patent for the technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.